Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, 12th November, 2022, inter-alia, to consider and approve:
1. The Un-audited Financial Results for the quarter and half year ended 30th September, 2022:
2. Other Corporate matters
As per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Code of conduct to Regulate, Monitor and Report Trading by insiders of the Company, the Trading window for dealing in the equity shares of the Company was closed from 01st October, 2022, till 48 hours after the declaration of financial results for the quarter and half year ended 30th September, 2022, for all designated persons, their immediate relatives and all connected persons covered under the said Code.
This is for your information and records.